343 related articles for article (PubMed ID: 1346584)
1. Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes.
Moley JF; Brother MB; Fong CT; White PS; Baylin SB; Nelkin B; Wells SA; Brodeur GM
Cancer Res; 1992 Feb; 52(4):770-4. PubMed ID: 1346584
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas.
Khosla S; Patel VM; Hay ID; Schaid DJ; Grant CS; van Heerden JA; Thibodeau SN
J Clin Invest; 1991 May; 87(5):1691-9. PubMed ID: 2022740
[TBL] [Abstract][Full Text] [Related]
3. Microarray-based CGH of sporadic and syndrome-related pheochromocytomas using a 0.1-0.2 Mb bacterial artificial chromosome array spanning chromosome arm 1p.
Aarts M; Dannenberg H; deLeeuw RJ; van Nederveen FH; Verhofstad AA; Lenders JW; Dinjens WN; Speel EJ; Lam WL; de Krijger RR
Genes Chromosomes Cancer; 2006 Jan; 45(1):83-93. PubMed ID: 16215979
[TBL] [Abstract][Full Text] [Related]
4. Loss of genes on chromosome 22 in medullary thyroid carcinoma and pheochromocytoma.
Takai S; Tateishi H; Nishisho I; Miki T; Motomura K; Miyauchi A; Kato M; Ikeuchi T; Yamamoto K; Okazaki M
Jpn J Cancer Res; 1987 Sep; 78(9):894-8. PubMed ID: 2889715
[TBL] [Abstract][Full Text] [Related]
5. Oncogene and growth factor expression in MEN 2 and related tumors.
Moley JF; Wallin GK; Brother MB; Kim M; Wells SA; Brodeur GM
Henry Ford Hosp Med J; 1992; 40(3-4):284-8. PubMed ID: 1362425
[TBL] [Abstract][Full Text] [Related]
6. Allele loss on chromosome 10 and point mutation of ras oncogenes are infrequent in tumors of MEN 2A.
Okazaki M; Miya A; Tanaka N; Miki T; Yamamoto M; Motomura K; Miyauchi A; Mori T; Takai S
Henry Ford Hosp Med J; 1989; 37(3-4):112-5. PubMed ID: 2576939
[TBL] [Abstract][Full Text] [Related]
7. Low incidence of loss of chromosome 10 in sporadic and hereditary human medullary thyroid carcinoma.
Nelkin BD; Nakamura Y; White RW; de Bustros AC; Herman J; Wells SA; Baylin SB
Cancer Res; 1989 Aug; 49(15):4114-9. PubMed ID: 2568166
[TBL] [Abstract][Full Text] [Related]
8. Deletion mapping on the distal third region of chromosome 1p in multiple endocrine neoplasia type IIA.
Yang KP; Nguyen CV; Castillo SG; Samaan NA
Anticancer Res; 1990; 10(2B):527-33. PubMed ID: 1972009
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity on the short arm of chromosome 1 in pheochromocytoma and abdominal paraganglioma.
Edström Elder E; Nord B; Carling T; Juhlin C; Bäckdahl M; Höög A; Larsson C
World J Surg; 2002 Aug; 26(8):965-71. PubMed ID: 12045857
[TBL] [Abstract][Full Text] [Related]
10. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
11. Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1p.
Benn DE; Dwight T; Richardson AL; Delbridge L; Bambach CP; Stowasser M; Gordon RD; Marsh DJ; Robinson BG
Cancer Res; 2000 Dec; 60(24):7048-51. PubMed ID: 11156410
[TBL] [Abstract][Full Text] [Related]
12. Selective loss of chromosome 11 in pheochromocytomas associated with the VHL syndrome.
Lui WO; Chen J; Gläsker S; Bender BU; Madura C; Khoo SK; Kort E; Larsson C; Neumann HP; Teh BT
Oncogene; 2002 Feb; 21(7):1117-22. PubMed ID: 11850829
[TBL] [Abstract][Full Text] [Related]
13. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.
Neumann HP; Berger DP; Sigmund G; Blum U; Schmidt D; Parmer RJ; Volk B; Kirste G
N Engl J Med; 1993 Nov; 329(21):1531-8. PubMed ID: 8105382
[TBL] [Abstract][Full Text] [Related]
14. Absence of TP53 alterations in pheochromocytomas and medullary thyroid carcinomas.
Herfarth KK; Wick MR; Marshall HN; Gartner E; Lum S; Moley JF
Genes Chromosomes Cancer; 1997 Sep; 20(1):24-9. PubMed ID: 9290950
[TBL] [Abstract][Full Text] [Related]
15. Deletion mapping of chromosome 1p and 22q in pheochromocytoma.
Shin E; Fujita S; Takami K; Kurahashi H; Kurita Y; Kobayashi T; Mori T; Nishisho I; Takai S
Jpn J Cancer Res; 1993 Apr; 84(4):402-8. PubMed ID: 8514606
[TBL] [Abstract][Full Text] [Related]
16. Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas.
Bender BU; Gutsche M; Gläsker S; Müller B; Kirste G; Eng C; Neumann HP
J Clin Endocrinol Metab; 2000 Dec; 85(12):4568-74. PubMed ID: 11134110
[TBL] [Abstract][Full Text] [Related]
17. Hereditary medullary thyroid carcinoma: genetic annalysis of three related syndromes. Groupe d'Etude des Tumeurs a Calcitonine.
Sobol H; Narod SA; Schuffenecker I; Amos C; Ezekowitz RA; Lenoir GM
Henry Ford Hosp Med J; 1989; 37(3-4):109-11. PubMed ID: 2576938
[TBL] [Abstract][Full Text] [Related]
18. Frequent loss of heterozygosity for markers on chromosome arm 10q in chondrosarcomas.
Raskind WH; Conrad EU; Matsushita M
Genes Chromosomes Cancer; 1996 Jun; 16(2):138-43. PubMed ID: 8818661
[TBL] [Abstract][Full Text] [Related]
19. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
Martinsson T; Sjöberg RM; Hedborg F; Kogner P
Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis, management, and pathogenetic studies in medullary thyroid carcinoma syndrome.
Samaan NA; Yang KP; Schultz P; Hickey RC
Henry Ford Hosp Med J; 1989; 37(3-4):132-7. PubMed ID: 2576946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
